{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T18:57:54Z","timestamp":1761764274580},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2004,6,29]],"date-time":"2004-06-29T00:00:00Z","timestamp":1088467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2004,6,29]],"date-time":"2004-06-29T00:00:00Z","timestamp":1088467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2004,9,1]]},"DOI":"10.1038\/sj.pcan.4500734","type":"journal-article","created":{"date-parts":[[2004,6,29]],"date-time":"2004-06-29T09:28:30Z","timestamp":1088501310000},"page":"258-262","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Learning curve and stage migration of a radical retropubic prostatectomy series over a 10-y period"],"prefix":"10.1038","volume":"7","author":[{"given":"M H","family":"Winkler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D A","family":"Gillatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2004,6,29]]},"reference":[{"key":"BF4500734_CR1","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/S0022-5347(17)32398-4","volume":"152","author":"M Ohori","year":"1994","unstructured":"Ohori M et al. Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? J Urol 1994; 152: 1843\u20131849.","journal-title":"J Urol"},{"key":"BF4500734_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1016\/S0022-5347(17)32395-9","volume":"152","author":"DF Paulson","year":"1994","unstructured":"Paulson DF . Impact of radical prostatectomy in the management of clinically localized disease. J Urol 1994; 152: 1826\u20131830.","journal-title":"J Urol"},{"key":"BF4500734_CR3","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/S0090-4295(96)00167-7","volume":"48","author":"P Kupelian","year":"1996","unstructured":"Kupelian P et al. Correlation of clinical and pathological factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Urology 1996; 48: 246\u2013260.","journal-title":"Urology"},{"key":"BF4500734_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/0090-4295(94)90144-9","volume":"43","author":"AL Zietman","year":"1994","unstructured":"Zietman AL et al. Radical prostatectomy for adenocarcinoma of the prostate: the influence of preoperative and pathological findings on biochemical disease-free outcome. Urology 1994; 43: 828\u2013833.","journal-title":"Urology"},{"key":"BF4500734_CR5","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1016\/S0022-5347(17)32396-0","volume":"152","author":"PC Walsh","year":"1994","unstructured":"Walsh PC, Partin AW, Ebstein JI . Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. J Urol 1994; 152: 1831\u20131836.","journal-title":"J Urol"},{"key":"BF4500734_CR6","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/S0022-5347(17)32394-7","volume":"152","author":"JG Trapasso","year":"1994","unstructured":"Trapasso JG, deKernion JB, Smith RB, Dorey F . The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994; 152: 1821\u20131825.","journal-title":"J Urol"},{"key":"BF4500734_CR7","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0090-4295(97)00106-4","volume":"50","author":"O Dillioglugil","year":"1997","unstructured":"Dillioglugil O et al. Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology 1997; 50: 93\u201399.","journal-title":"Urology"},{"key":"BF4500734_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1046\/j.1464-410X.2003.04083.x","volume":"91","author":"SE Oliver","year":"2003","unstructured":"Oliver SE et al. Recent trends in the use of radical prostatectomy in England: the epidemiology of diffusion. BJU Int 2003; 91: 331\u2013336, (discussion 336).","journal-title":"BJU Int"},{"key":"BF4500734_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4899-3115-3","volume-title":"Modelling Survival Data in Medical Research","author":"D Collett","year":"1994","unstructured":"Collett D . Modelling Survival Data in Medical Research. Chapman & Hall: London, 1994."},{"key":"BF4500734_CR10","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch PM, Therneau TM . Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515\u2013526.","journal-title":"Biometrika"},{"key":"BF4500734_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0090-4295(99)80089-2","volume":"45","author":"SE Litwiller","year":"1995","unstructured":"Litwiller SE et al. Radical retropubic prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: changing trends over a 10-year period (1984\u20131994). Dallas Outcomes Research Group for Urological Disorders. Urology 1995; 45: 813\u2013822.","journal-title":"Urology"},{"key":"BF4500734_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1067\/msy.2002.125315","volume":"132","author":"JW Moul","year":"2002","unstructured":"Moul JW et al. Epidemiology of radical prostatectomy for localized prostate cancer in the era of prostate-specific antigen: an overview of the Department of Defense Center for Prostate Disease Research national database. Surgery 2002; 132: 213\u2013219.","journal-title":"Surgery"},{"key":"BF4500734_CR13","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1016\/S0090-4295(02)02526-8","volume":"61","author":"SJ Freedland","year":"2003","unstructured":"Freedland SJ et al. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database. Urology 2003; 61: 736\u2013741.","journal-title":"Urology"},{"key":"BF4500734_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/S0090-4295(02)01814-9","volume":"60","author":"JO Ung","year":"2002","unstructured":"Ung JO et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. Urology 2002; 60: 458\u2013463.","journal-title":"Urology"},{"key":"BF4500734_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/cncr.10657","volume":"95","author":"AV D\u2019Amico","year":"2002","unstructured":"D\u2019Amico AV et al. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer 2002; 95: 281\u2013286.","journal-title":"Cancer"},{"key":"BF4500734_CR16","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","volume":"169","author":"M Han","year":"2003","unstructured":"Han M et al. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer. J Urol 2003; 169: 517\u2013523.","journal-title":"J Urol"},{"key":"BF4500734_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3322\/canjclin.49.5.282","volume":"49","author":"WJ Catalona","year":"1999","unstructured":"Catalona WJ, Ramos CG, Carvalhal GF . Contemporary results of anatomic radical prostatectomy. CA Cancer J Clin 1999; 49: 282\u2013296.","journal-title":"CA Cancer J Clin"},{"issue":"2 Part 1","key":"BF4500734_CR18","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/S0022-5347(01)69079-7","volume":"167","author":"GW Hull","year":"2002","unstructured":"Hull GW et al. Cancer control with radical prostatectomy alone in 1,000 consecutive patients. J Urol 2002; 167 (2 Part 1): 528\u2013534.","journal-title":"J Urol"},{"key":"BF4500734_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1054\/bjoc.2001.1962","volume":"85","author":"J Melia","year":"2001","unstructured":"Melia J, Moss S . Survey of the rate of PSA testing in general practice. Br J Cancer 2001; 85: 656\u2013657.","journal-title":"Br J Cancer"},{"key":"BF4500734_CR20","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1200\/JCO.2003.05.169","volume":"21","author":"JC Hu","year":"2003","unstructured":"Hu JC et al. Role of surgeon volume in radical prostatectomy outcomes. J Clin Oncol 2003; 21: 401\u2013405.","journal-title":"J Clin Oncol"},{"key":"BF4500734_CR21","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S0022-5347(05)67821-4","volume":"163","author":"LM Ellison","year":"2000","unstructured":"Ellison LM, Heaney JA, Birkmeyer JD . The effect of hospital volume on mortality and resource use after radical prostatectomy. J Urol 2000; 163: 867\u2013869.","journal-title":"J Urol"},{"key":"BF4500734_CR22","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/jnci\/91.22.1950","volume":"91","author":"SL Yao","year":"1999","unstructured":"Yao SL, Lu-Yao G . Population-based study of relationships between hospital volume of prostatectomies, patient outcomes, and length of hospital stay. J Natl Cancer Inst 1999; 91: 1950\u20131956.","journal-title":"J Natl Cancer Inst"},{"key":"BF4500734_CR23","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1056\/NEJMoa012794","volume":"347","author":"L Holmberg","year":"2002","unstructured":"Holmberg L et al. A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781\u2013789.","journal-title":"N Engl J Med"}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/4500734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500734","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/4500734.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:48:14Z","timestamp":1648680494000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/4500734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,29]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9,1]]}},"alternative-id":["BF4500734"],"URL":"https:\/\/doi.org\/10.1038\/sj.pcan.4500734","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,29]]},"assertion":[{"value":"18 January 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2004","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2004","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2004","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}